经验

Keymed Biosciences – HK$3.1 Billion IPO

July 8, 2021

Cooley advised biotechnology company Keymed Biosciences on its HK$3.1 billion (US$400 million) initial public offering on the Hong Kong Stock Exchange. Partners Yiming Liu, Michael Yu and Will Cai led the Cooley team advising Keymed Biosciences on its public debut, which also included Yiying Wang, Xiaoyu Xu, Kaiting Yang, Henry Wang, Bridget Wang and Iris Yang.

Read more

Related contacts

刘毅铭
上海办事处主管合伙人, 上海
余仙
香港办事处主管合伙人, 香港
蔡华
合伙人, 香港
王一盈
顾问律师, 上海
杨凯婷
顾问律师, 香港
Calvin Lee
Associate, 纽约

Related Practices & Industries

Asymchem Laboratories – HK$7.15 Billion IPO

December 15, 2021

Cooley advised Asymchem Laboratories, a contract development manufacturing organization (CDMO) serving the global pharmaceutical industry, on its HK$7.15 billion (US$916 million) initial public offering – marking the largest healthcare IPO in Hong Kong this year – of 18,415,400 H shares, which now trade on the Hong Kong Stock Exchange. Partners Yiming Liu and Michael Yu led the Cooley team advising Asymchem.

Read more

Related contacts

刘毅铭
上海办事处主管合伙人, 上海
余仙
香港办事处主管合伙人, 香港
王一盈
顾问律师, 上海
杨凯婷
顾问律师, 香港
武梦超
律师, 北京
Cindy Pan
International Legal Project Manager, 香港
Rick Jantz
Associate, 洛杉矶
Francis Wheeler
Senior Counsel, 科罗拉多

Related Practices & Industries

Huitongda Network – HK$2.2 Billion IPO

February 19, 2022

Cooley advised the joint sponsors and underwriters on ecommerce company Huitongda’s HK$2.2 billion (US$285 million) initial public offering of 51,606,200 H shares on the Hong Kong Stock Exchange, subject to the exercise of the underwriters’ option to purchase an additional 7,740,900 H shares. Partners Michael Yu and Will Cai led the Cooley team advising the joint sponsors and underwriters.

Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
蔡华
合伙人, 香港
袁晓通
资深顾问律师, 北京
杨凯婷
顾问律师, 香港
段棣淳
律师, 北京
武梦超
律师, 北京
Jingxian Huang
Associate, 北京
王冰清
国际法律项目经理, 上海
Francis Wheeler
Senior Counsel, 科罗拉多
Eric Blanchard
Partner, 波士顿
Kevin King
Partner, 华盛顿特区
Karen Tsai
Special Counsel, 华盛顿特区

Related Practices & Industries

STAR CM – HK$390 Million IPO

January 5, 2023

Cooley advised STAR CM, a variety program intellectual property creator and operator, on its HK$390 million ($50 million) initial public offering of 14,731,600 shares at a public offering price of HK$26.50 on the Hong Kong Stock Exchange, subject to the overallotment option.
Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
蔡华
合伙人, 香港
袁晓通
资深顾问律师, 北京
杨凯婷
顾问律师, 香港
Francis Wheeler
Senior Counsel, 科罗拉多
王帅文
国际法律项目经理, 北京
Cindy Pan
International Legal Project Manager, 香港
Philip Kwan
Senior Legal Assistant, 香港
王冰清
国际法律项目经理, 上海

Cryofocus Medtech – HK$210 Million IPO

January 5, 2023

Cooley advised the joint sponsors and underwriters of Cryofocus Medtech’s HK$210 million ($27 million) initial public offering of 11,110,000 H Shares on the Hong Kong Stock Exchange.
Read more

Related contacts

余仙
香港办事处主管合伙人, 香港
刘毅铭
上海办事处主管合伙人, 上海
蔡华
合伙人, 香港
杨凯婷
顾问律师, 香港
王一盈
顾问律师, 上海
徐云翔
律师, 上海
刘学谦
律师, 香港
吴茜
律师, 上海
李正洋
国际法律项目经理, 香港
查看全部

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.